Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sergliflozin etabonate (KGT-1251) is an inhibitor of SGLT2 and can be used in studies about type 2 diabetes and obesity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 195.00 | |
2 mg | In stock | $ 293.00 | |
5 mg | In stock | $ 448.00 | |
10 mg | In stock | $ 658.00 | |
25 mg | In stock | $ 987.00 | |
50 mg | In stock | $ 1,380.00 | |
100 mg | In stock | $ 1,890.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 516.00 |
Description | Sergliflozin etabonate (KGT-1251) is an inhibitor of SGLT2 and can be used in studies about type 2 diabetes and obesity. |
Synonyms | GW-869682, GW-869682X, KGT-1251, GW869682X, GW869682, KGT1251 |
Molecular Weight | 448.46 |
Formula | C23H28O9 |
CAS No. | 408504-26-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (111.49 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sergliflozin etabonate 408504-26-7 GPCR/G Protein SGLT GW-869682 GW-869682X KGT-1251 GW 869682 GW869682X GW869682 KGT 1251 KGT1251 inhibitor inhibit